NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes

NCT04945330 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion

Interventions

DRUG: Larotrectinib (Vitrakvi, BAY2757556)

Sponsor

Bayer